$DNTH filed an 8-K with results (Item 2.02) at 4:03 PM ET on Wed, Nov 4.
Vote
DNTH
Dianthus Therapeutics, Inc.About DNTH
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Why it moved
Moved with Pharmaceuticals peers: RYTM +21.67% · VRDN +15.49% · XNCR +14.26%
From market data · Not investment advice
Why it moved
Moved with Pharmaceuticals peers: RYTM +21.67% · VRDN +15.49% · XNCR +14.26%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check 7:30 PM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about DNTH?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›